I did imply it wasn't a big deal. I hope I'm proved wrong and they sign plenty of deals however Australia is not a priority, never has been and because of that I don't think much effort will be put into Australia in comparison to larger markets like the US, China, India and regions of Europe.
I guess the market felt the same as me. Handy to have but not comparable to the Taiwan announcement because we had a HUGE MOU which everyone got amped about. With this announcement all we have is a distribution agreement with a very very small company.
It's a positive announcement and it deserved an increase in value however it was never going to be huge. FDA approval and the likes on the other hand would be substantial.